<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">39064139</PMID><DateRevised><Year>2024</Year><Month>07</Month><Day>29</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Print">2077-0383</ISSN><JournalIssue CitedMedium="Print"><Volume>13</Volume><Issue>14</Issue><PubDate><Year>2024</Year><Month>Jul</Month><Day>13</Day></PubDate></JournalIssue><Title>Journal of clinical medicine</Title><ISOAbbreviation>J Clin Med</ISOAbbreviation></Journal><ArticleTitle>Importance of Blood Glucose Measurement for Predicting the Prognosis of Long COVID: A Retrospective Study in Japan.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">4099</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/jcm13144099</ELocationID><Abstract><AbstractText><b>Purpose:</b> The present study aimed to clarify the effects of a hyperglycemic condition on the clinical consequences of long COVID. <b>Methods:</b> Among 643 patients who visited the outpatient clinic of our hospital from February 2021 to September 2023, long COVID patients were classified into a hyperglycemic (HG) group with casual blood glucose levels above 140 mg/dL and a normoglycemic (NG) group. The patients' backgrounds, clinical symptoms, health status including the QOL evaluation scale (EQ-5D-5L), self-rating depression scale (SDS), and F-scale questionnaire (FSSG), blood test data, and recovery periods were analyzed. <b>Results:</b> The NG group included 607 patients with long COVID and the HG group included 36 patients with long COVID. Patients in the HG group were older than those in the NG group (55 vs. 41 years; <i>p</i> &lt; 0.001) and included a larger percentage of males (67% vs. 44%; <i>p</i> = 0.009). The HG group had a larger percentage of patients with moderate-to-severe conditions in the acute infection phase (28% vs. 12%; <i>p</i> = 0.008), a higher BMI (25 vs. 22 kg/m<sup>2</sup>; <i>p</i> &lt; 0.001), higher blood pressure (138/81 vs. 122/72 mmHg; <i>p</i> &lt; 0.001), and a larger percentage of patients with an alcohol drinking habit (53% vs. 34%; <i>p</i> = 0.031). Long COVID symptoms and self-rated scales were not differed between the two groups; however, the laboratory data showed that liver and renal functions and metabolic data were significantly worse in the HG group. Although there was no apparent difference between the two groups in duration from the infection to the first visit, the HG group had a significantly longer period of recovery from long COVID (median period of 421 vs. 294 days; <i>p</i> = 0.019). <b>Conclusion:</b> A hyperglycemic state associated with other lifestyle-related diseases is associated with the prolongation of recovery from long COVID.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Yokoyama</LastName><ForeName>Sho</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of General Medicine, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, 2-5-1 Shikata-cho, Kita-ku, Okayama 700-8558, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Honda</LastName><ForeName>Hiroyuki</ForeName><Initials>H</Initials><Identifier Source="ORCID">0000-0001-6098-5006</Identifier><AffiliationInfo><Affiliation>Department of General Medicine, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, 2-5-1 Shikata-cho, Kita-ku, Okayama 700-8558, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Otsuka</LastName><ForeName>Yuki</ForeName><Initials>Y</Initials><Identifier Source="ORCID">0000-0001-6015-6128</Identifier><AffiliationInfo><Affiliation>Department of General Medicine, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, 2-5-1 Shikata-cho, Kita-ku, Okayama 700-8558, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tokumasu</LastName><ForeName>Kazuki</ForeName><Initials>K</Initials><Identifier Source="ORCID">0000-0001-9513-6864</Identifier><AffiliationInfo><Affiliation>Department of General Medicine, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, 2-5-1 Shikata-cho, Kita-ku, Okayama 700-8558, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nakano</LastName><ForeName>Yasuhiro</ForeName><Initials>Y</Initials><Identifier Source="ORCID">0000-0001-9972-791X</Identifier><AffiliationInfo><Affiliation>Department of General Medicine, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, 2-5-1 Shikata-cho, Kita-ku, Okayama 700-8558, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sakurada</LastName><ForeName>Yasue</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of General Medicine, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, 2-5-1 Shikata-cho, Kita-ku, Okayama 700-8558, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Matsuda</LastName><ForeName>Yui</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of General Medicine, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, 2-5-1 Shikata-cho, Kita-ku, Okayama 700-8558, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sunada</LastName><ForeName>Naruhiko</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Department of General Medicine, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, 2-5-1 Shikata-cho, Kita-ku, Okayama 700-8558, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hasegawa</LastName><ForeName>Toru</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of General Medicine, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, 2-5-1 Shikata-cho, Kita-ku, Okayama 700-8558, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Takase</LastName><ForeName>Ryosuke</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of General Medicine, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, 2-5-1 Shikata-cho, Kita-ku, Okayama 700-8558, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Omura</LastName><ForeName>Daisuke</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of General Medicine, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, 2-5-1 Shikata-cho, Kita-ku, Okayama 700-8558, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Soejima</LastName><ForeName>Yoshiaki</ForeName><Initials>Y</Initials><Identifier Source="ORCID">0000-0002-2070-3892</Identifier><AffiliationInfo><Affiliation>Department of General Medicine, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, 2-5-1 Shikata-cho, Kita-ku, Okayama 700-8558, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ueda</LastName><ForeName>Keigo</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of General Medicine, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, 2-5-1 Shikata-cho, Kita-ku, Okayama 700-8558, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kishida</LastName><ForeName>Masayuki</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of General Medicine, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, 2-5-1 Shikata-cho, Kita-ku, Okayama 700-8558, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Otsuka</LastName><ForeName>Fumio</ForeName><Initials>F</Initials><Identifier Source="ORCID">0000-0001-7014-9095</Identifier><AffiliationInfo><Affiliation>Department of General Medicine, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, 2-5-1 Shikata-cho, Kita-ku, Okayama 700-8558, Japan.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>23fk0108585h0001</GrantID><Agency>Japan Agency for Medical Research and Development</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>07</Month><Day>13</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>J Clin Med</MedlineTA><NlmUniqueID>101606588</NlmUniqueID><ISSNLinking>2077-0383</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">blood glucose</Keyword><Keyword MajorTopicYN="N">diabetes mellitus</Keyword><Keyword MajorTopicYN="N">long COVID</Keyword><Keyword MajorTopicYN="N">omicron variant</Keyword><Keyword MajorTopicYN="N">post-COVID-19 condition</Keyword></KeywordList><CoiStatement>The authors declare no conflicts of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>5</Month><Day>24</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2024</Year><Month>6</Month><Day>22</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>7</Month><Day>10</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>7</Month><Day>27</Day><Hour>10</Hour><Minute>49</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>7</Month><Day>27</Day><Hour>10</Hour><Minute>48</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>7</Month><Day>27</Day><Hour>1</Hour><Minute>19</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>7</Month><Day>13</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39064139</ArticleId><ArticleId IdType="pmc">PMC11277581</ArticleId><ArticleId IdType="doi">10.3390/jcm13144099</ArticleId><ArticleId IdType="pii">jcm13144099</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Shrestha L.B., Foster C., Rawlinson W., Tedla N., Bull R.A. Evolution of the SARS-CoV-2 omicron variants BA.1 to BA.5: Implications for immune escape and transmission. Rev. Med. Virol. 2022;32:e2381. doi: 10.1002/rmv.2381.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/rmv.2381</ArticleId><ArticleId IdType="pmc">PMC9349777</ArticleId><ArticleId IdType="pubmed">35856385</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang C., Wang Y., Li X., Ren L., Zhao J., Hu Y., Zhang L., Fan G., Xu J., Gu X., et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395:497&#x2013;506. doi: 10.1016/S0140-6736(20)30183-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(20)30183-5</ArticleId><ArticleId IdType="pmc">PMC7159299</ArticleId><ArticleId IdType="pubmed">31986264</ArticleId></ArticleIdList></Reference><Reference><Citation>Nalbandian A., Sehgal K., Gupta A., Madhavan M.V., McGroder C., Stevens J.S., Cook J.R., Nordvig A.S., Shalev D., Sehrawat T.S., et al. Post-acute COVID-19 syndrome. Nat. Med. 2021;27:601&#x2013;615. doi: 10.1038/s41591-021-01283-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-021-01283-z</ArticleId><ArticleId IdType="pmc">PMC8893149</ArticleId><ArticleId IdType="pubmed">33753937</ArticleId></ArticleIdList></Reference><Reference><Citation>Raveendran A.V., Jayadevan R., Sashidharan S. Long COVID: An overview. Diabetes Metab. Syndr. 2021;15:869&#x2013;875. doi: 10.1016/j.dsx.2021.04.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.dsx.2021.04.007</ArticleId><ArticleId IdType="pmc">PMC8056514</ArticleId><ArticleId IdType="pubmed">33892403</ArticleId></ArticleIdList></Reference><Reference><Citation>Soriano J.B., Murthy S., Marshall J.C., Relan P., Diaz J.V., WHO Clinical Case Definition Working Group on Post-COVID-19 Condition A clinical case definition of post-COVID-19 condition by a Delphi consensus. Lancet Infect. Dis. 2022;22:e102&#x2013;e107. doi: 10.1016/S1473-3099(21)00703-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(21)00703-9</ArticleId><ArticleId IdType="pmc">PMC8691845</ArticleId><ArticleId IdType="pubmed">34951953</ArticleId></ArticleIdList></Reference><Reference><Citation>Ballering A.V., van Zon S.K.R., Olde Hartman T.C., Rosmalen J.G.M., Lifelines Corona Research I. Persistence of somatic symptoms after COVID-19 in the Netherlands: An observational cohort study. Lancet. 2022;400:452&#x2013;461. doi: 10.1016/S0140-6736(22)01214-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(22)01214-4</ArticleId><ArticleId IdType="pmc">PMC9352274</ArticleId><ArticleId IdType="pubmed">35934007</ArticleId></ArticleIdList></Reference><Reference><Citation>Davis H.E., McCorkell L., Vogel J.M., Topol E.J. Long COVID: Major findings, mechanisms and recommendations. Nat. Rev. Microbiol. 2023;21:133&#x2013;146. doi: 10.1038/s41579-022-00846-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41579-022-00846-2</ArticleId><ArticleId IdType="pmc">PMC9839201</ArticleId><ArticleId IdType="pubmed">36639608</ArticleId></ArticleIdList></Reference><Reference><Citation>Davis H.E., Assaf G.S., McCorkell L., Wei H., Low R.J., Re&#x2019;em Y., Redfield S., Austin J.P., Akrami A. Characterizing long COVID in an international cohort: 7 months of symptoms and their impact. EClinicalMedicine. 2021;38:101019. doi: 10.1016/j.eclinm.2021.101019.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.eclinm.2021.101019</ArticleId><ArticleId IdType="pmc">PMC8280690</ArticleId><ArticleId IdType="pubmed">34308300</ArticleId></ArticleIdList></Reference><Reference><Citation>Sunada N., Nakano Y., Otsuka Y., Tokumasu K., Honda H., Sakurada Y., Matsuda Y., Hasegawa T., Omura D., Ochi K., et al. Characteristics of Sleep Disturbance in Patients with Long COVID: A Retrospective Observational Study in Japan. J. Clin. Med. 2022;11:7332. doi: 10.3390/jcm11247332.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm11247332</ArticleId><ArticleId IdType="pmc">PMC9783729</ArticleId><ArticleId IdType="pubmed">36555948</ArticleId></ArticleIdList></Reference><Reference><Citation>Nakano Y., Otsuka Y., Honda H., Sunada N., Tokumasu K., Sakurada Y., Matsuda Y., Hasegawa T., Ochi K., Hagiya H., et al. Transitional Changes in Fatigue-Related Symptoms Due to Long COVID: A Single-Center Retrospective Observational Study in Japan. Medicina. 2022;58:1393. doi: 10.3390/medicina58101393.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/medicina58101393</ArticleId><ArticleId IdType="pmc">PMC9611667</ArticleId><ArticleId IdType="pubmed">36295554</ArticleId></ArticleIdList></Reference><Reference><Citation>Kawai T., Autieri M.V., Scalia R. Adipose tissue inflammation and metabolic dysfunction in obesity. Am. J. Physiol. Cell Physiol. 2021;320:C375&#x2013;C391. doi: 10.1152/ajpcell.00379.2020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/ajpcell.00379.2020</ArticleId><ArticleId IdType="pmc">PMC8294624</ArticleId><ArticleId IdType="pubmed">33356944</ArticleId></ArticleIdList></Reference><Reference><Citation>Suganami T., Tanaka M., Ogawa Y. Adipose tissue inflammation and ectopic lipid accumulation. Endocr. J. 2012;59:849&#x2013;857. doi: 10.1507/endocrj.EJ12-0271.</Citation><ArticleIdList><ArticleId IdType="doi">10.1507/endocrj.EJ12-0271</ArticleId><ArticleId IdType="pubmed">22878669</ArticleId></ArticleIdList></Reference><Reference><Citation>Iacobellis G. COVID-19 and diabetes: Can DPP4 inhibition play a role? Diabetes Res. Clin. Pract. 2020;162:108125. doi: 10.1016/j.diabres.2020.108125.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.diabres.2020.108125</ArticleId><ArticleId IdType="pmc">PMC7271223</ArticleId><ArticleId IdType="pubmed">32224164</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou Y., Chi J., Lv W., Wang Y. Obesity and diabetes as high-risk factors for severe coronavirus disease 2019 (COVID-19) Diabetes Metab. Res. Rev. 2021;37:e3377. doi: 10.1002/dmrr.3377.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/dmrr.3377</ArticleId><ArticleId IdType="pmc">PMC7361201</ArticleId><ArticleId IdType="pubmed">32588943</ArticleId></ArticleIdList></Reference><Reference><Citation>Klein J., Wood J., Jaycox J., Dhodapkar R.M., Lu P., Gehlhausen J.R., Tabachnikova A., Greene K., Tabacof L., Malik A.A., et al. Distinguishing features of Long COVID identified through immune profiling. Nature. 2023;623:139&#x2013;148. doi: 10.1038/s41586-023-06651-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-023-06651-y</ArticleId><ArticleId IdType="pmc">PMC10620090</ArticleId><ArticleId IdType="pubmed">37748514</ArticleId></ArticleIdList></Reference><Reference><Citation>Monje M., Iwasaki A. The neurobiology of long COVID. Neuron. 2022;110:3484&#x2013;3496. doi: 10.1016/j.neuron.2022.10.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2022.10.006</ArticleId><ArticleId IdType="pmc">PMC9537254</ArticleId><ArticleId IdType="pubmed">36288726</ArticleId></ArticleIdList></Reference><Reference><Citation>Siso-Almirall A., Brito-Zeron P., Conangla Ferrin L., Kostov B., Moragas Moreno A., Mestres J., Sellares J., Galindo G., Morera R., Basora J., et al. Long COVID-19: Proposed Primary Care Clinical Guidelines for Diagnosis and Disease Management. Int. J. Environ. Res. Public Health. 2021;18:4350. doi: 10.3390/ijerph18084350.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijerph18084350</ArticleId><ArticleId IdType="pmc">PMC8073248</ArticleId><ArticleId IdType="pubmed">33923972</ArticleId></ArticleIdList></Reference><Reference><Citation>Saand A.R., Flores M., Kewan T., Alqaisi S., Alwakeel M., Griffiths L., Wang X., Han X., Burton R., Al-Jaghbeer M.J., et al. Does inpatient hyperglycemia predict a worse outcome in COVID-19 intensive care unit patients? J. Diabetes. 2021;13:253&#x2013;260. doi: 10.1111/1753-0407.13137.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/1753-0407.13137</ArticleId><ArticleId IdType="pmc">PMC7753721</ArticleId><ArticleId IdType="pubmed">33216443</ArticleId></ArticleIdList></Reference><Reference><Citation>American Diabetes A. Diagnosis and classification of diabetes mellitus. Diabetes Care. 2010;33((Suppl. S1)):S62&#x2013;S69. doi: 10.2337/dc10-S062.</Citation><ArticleIdList><ArticleId IdType="doi">10.2337/dc10-S062</ArticleId><ArticleId IdType="pmc">PMC2797383</ArticleId><ArticleId IdType="pubmed">20042775</ArticleId></ArticleIdList></Reference><Reference><Citation>Tokumasu K., Ueda K., Honda H., Sunada N., Sakurada Y., Matsuda Y., Nakano Y., Hasegawa T., Otsuka Y., Obika M., et al. Application of Kampo Medicines for Treatment of General Fatigue Due to Long COVID. Medicina. 2022;58:730. doi: 10.3390/medicina58060730.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/medicina58060730</ArticleId><ArticleId IdType="pmc">PMC9227280</ArticleId><ArticleId IdType="pubmed">35743993</ArticleId></ArticleIdList></Reference><Reference><Citation>Onoda T., Tanaka H., Ishii T. Bibliometric analysis of Kampo medicine hotspots and trends for the decade: 2013&#x2013;2022. Medicine. 2023;102:e35897. doi: 10.1097/MD.0000000000035897.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/MD.0000000000035897</ArticleId><ArticleId IdType="pmc">PMC10627683</ArticleId><ArticleId IdType="pubmed">37932994</ArticleId></ArticleIdList></Reference><Reference><Citation>De Vries J., Michielsen H., Van Heck G.L., Drent M. Measuring fatigue in sarcoidosis: The Fatigue Assessment Scale (FAS) Br. J. Health Psychol. 2004;9:279&#x2013;291. doi: 10.1348/1359107041557048.</Citation><ArticleIdList><ArticleId IdType="doi">10.1348/1359107041557048</ArticleId><ArticleId IdType="pubmed">15296678</ArticleId></ArticleIdList></Reference><Reference><Citation>Shiroiwa T., Ikeda S., Noto S., Igarashi A., Fukuda T., Saito S., Shimozuma K. Comparison of Value Set Based on DCE and/or TTO Data: Scoring for EQ-5D-5L Health States in Japan. Value Health. 2016;19:648&#x2013;654. doi: 10.1016/j.jval.2016.03.1834.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jval.2016.03.1834</ArticleId><ArticleId IdType="pubmed">27565282</ArticleId></ArticleIdList></Reference><Reference><Citation>Kusano M., Shimoyama Y., Sugimoto S., Kawamura O., Maeda M., Minashi K., Kuribayashi S., Higuchi T., Zai H., Ino K., et al. Development and evaluation of FSSG: Frequency scale for the symptoms of GERD. J. Gastroenterol. 2004;39:888&#x2013;891. doi: 10.1007/s00535-004-1417-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00535-004-1417-7</ArticleId><ArticleId IdType="pubmed">15565409</ArticleId></ArticleIdList></Reference><Reference><Citation>Beau Lotto R. Visual development: Experience puts the colour in life. Curr. Biol. 2004;14:R619&#x2013;R621. doi: 10.1016/j.cub.2004.07.045.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cub.2004.07.045</ArticleId><ArticleId IdType="pubmed">15296778</ArticleId></ArticleIdList></Reference><Reference><Citation>Kato Y. Case Management of COVID-19 (Secondary Version) JMA J. 2021;4:191&#x2013;197. doi: 10.31662/jmaj.2021-0036.</Citation><ArticleIdList><ArticleId IdType="doi">10.31662/jmaj.2021-0036</ArticleId><ArticleId IdType="pmc">PMC8355701</ArticleId><ArticleId IdType="pubmed">34414312</ArticleId></ArticleIdList></Reference><Reference><Citation>Kanda Y. Investigation of the freely available easy-to-use software &#x2018;EZR&#x2019; for medical statistics. Bone Marrow Transplant. 2013;48:452&#x2013;458. doi: 10.1038/bmt.2012.244.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/bmt.2012.244</ArticleId><ArticleId IdType="pmc">PMC3590441</ArticleId><ArticleId IdType="pubmed">23208313</ArticleId></ArticleIdList></Reference><Reference><Citation>Sone H., Ito H., Ohashi Y., Akanuma Y., Yamada N., Japan Diabetes Complication Study G. Obesity and type 2 diabetes in Japanese patients. Lancet. 2003;361:85. doi: 10.1016/S0140-6736(03)12151-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(03)12151-4</ArticleId><ArticleId IdType="pubmed">12517507</ArticleId></ArticleIdList></Reference><Reference><Citation>Iimura O. Insulin resistance and hypertension in Japanese. Hypertens. Res. 1996;19((Suppl. S1)):S1&#x2013;S8. doi: 10.1291/hypres.19.SupplementI_S1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1291/hypres.19.SupplementI_S1</ArticleId><ArticleId IdType="pubmed">9240755</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang X., Yu Y., Xu J., Shu H., Xia J., Liu H., Wu Y., Zhang L., Yu Z., Fang M., et al. Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: A single-centered, retrospective, observational study. Lancet Respir. Med. 2020;8:475&#x2013;481. doi: 10.1016/S2213-2600(20)30079-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2213-2600(20)30079-5</ArticleId><ArticleId IdType="pmc">PMC7102538</ArticleId><ArticleId IdType="pubmed">32105632</ArticleId></ArticleIdList></Reference><Reference><Citation>Guan W.J., Ni Z.Y., Hu Y., Liang W.H., Ou C.Q., He J.X., Liu L., Shan H., Lei C.L., Hui D.S.C., et al. Clinical Characteristics of Coronavirus Disease 2019 in China. N. Engl. J. Med. 2020;382:1708&#x2013;1720. doi: 10.1056/NEJMoa2002032.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa2002032</ArticleId><ArticleId IdType="pmc">PMC7092819</ArticleId><ArticleId IdType="pubmed">32109013</ArticleId></ArticleIdList></Reference><Reference><Citation>Albai O., Braha A., Timar B., Sima A., Deaconu L., Timar R. Assessment of the Negative Factors for the Clinical Outcome in Patients with SARS-CoV-2 Infection and Type 2 Diabetes Mellitus. Diabetes Metab. Syndr. Obes. 2024;17:271&#x2013;282. doi: 10.2147/DMSO.S447835.</Citation><ArticleIdList><ArticleId IdType="doi">10.2147/DMSO.S447835</ArticleId><ArticleId IdType="pmc">PMC10812141</ArticleId><ArticleId IdType="pubmed">38283636</ArticleId></ArticleIdList></Reference><Reference><Citation>Aon M., Alsaeedi A., Alzafiri A., Al-Shammari A., Taha S., Al-Shammari O., Tawakul M., Alshammari J., Alherz N., Alenezi M., et al. Stress Hyperglycemia Ratio as a Prognostic Marker in Diabetic Patients Hospitalized with COVID-19. Infect. Dis. Rep. 2022;14:675&#x2013;685. doi: 10.3390/idr14050073.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/idr14050073</ArticleId><ArticleId IdType="pmc">PMC9498653</ArticleId><ArticleId IdType="pubmed">36136823</ArticleId></ArticleIdList></Reference><Reference><Citation>de Almeida-Pititto B., Dualib P.M., Zajdenverg L., Dantas J.R., de Souza F.D., Rodacki M., Bertoluci M.C., Brazilian Diabetes Society Study G. Severity and mortality of COVID-19 in patients with diabetes, hypertension and cardiovascular disease: A meta-analysis. Diabetol. Metab. Syndr. 2020;12:75. doi: 10.1186/s13098-020-00586-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13098-020-00586-4</ArticleId><ArticleId IdType="pmc">PMC7456786</ArticleId><ArticleId IdType="pubmed">32874207</ArticleId></ArticleIdList></Reference><Reference><Citation>Raveendran A.V., Misra A. Post COVID-19 Syndrome (&#x201c;Long COVID&#x201d;) and Diabetes: Challenges in Diagnosis and Management. Diabetes Metab. Syndr. 2021;15:102235. doi: 10.1016/j.dsx.2021.102235.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.dsx.2021.102235</ArticleId><ArticleId IdType="pmc">PMC8317446</ArticleId><ArticleId IdType="pubmed">34384972</ArticleId></ArticleIdList></Reference><Reference><Citation>Sakurada Y., Sunada N., Honda H., Tokumasu K., Otsuka Y., Nakano Y., Hanayama Y., Furukawa M., Hagiya H., Otsuka F. Serial Changes of Long COVID Symptoms and Clinical Utility of Serum Antibody Titers for Evaluation of Long COVID. J. Clin. Med. 2022;11:1309. doi: 10.3390/jcm11051309.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm11051309</ArticleId><ArticleId IdType="pmc">PMC8911256</ArticleId><ArticleId IdType="pubmed">35268400</ArticleId></ArticleIdList></Reference><Reference><Citation>Jankowska A., Golicki D. EQ-5D-5L-based quality of life normative data for patients with self-reported diabetes in Poland. PLoS ONE. 2021;16:e0257998. doi: 10.1371/journal.pone.0257998.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0257998</ArticleId><ArticleId IdType="pmc">PMC8480847</ArticleId><ArticleId IdType="pubmed">34587218</ArticleId></ArticleIdList></Reference><Reference><Citation>Hamahara J., Honda H., Yamamoto K., Tokumasu K., Hanayama Y., Hagiya H., Obika M., Ueda K., Kishida M., Otsuka F. Clinical Characteristics of Low Androgen Status in Males with Type 2 Diabetes Mellitus. Acta Med. Okayama. 2021;75:1&#x2013;8. doi: 10.18926/AMO/61424.</Citation><ArticleIdList><ArticleId IdType="doi">10.18926/AMO/61424</ArticleId><ArticleId IdType="pubmed">33649607</ArticleId></ArticleIdList></Reference><Reference><Citation>Honda H., Hanayama Y., Obika M., Hasegawa K., Hamahara J., Kishida M., Hagiya H., Ogawa H., Kataoka H., Otsuka F. Clinical Relevance of Blood Glucose and Gastroesophageal Reflux Symptoms to Depressive Status in Patients with Type 2 Diabetes Mellitus. Acta Med. Okayama. 2020;74:33&#x2013;40. doi: 10.18926/AMO/57950.</Citation><ArticleIdList><ArticleId IdType="doi">10.18926/AMO/57950</ArticleId><ArticleId IdType="pubmed">32099246</ArticleId></ArticleIdList></Reference><Reference><Citation>Ford E.S., Cogswell M.E. Diabetes and serum ferritin concentration among U.S. adults. Diabetes Care. 1999;22:1978&#x2013;1983. doi: 10.2337/diacare.22.12.1978.</Citation><ArticleIdList><ArticleId IdType="doi">10.2337/diacare.22.12.1978</ArticleId><ArticleId IdType="pubmed">10587829</ArticleId></ArticleIdList></Reference><Reference><Citation>Tuomainen T.P., Nyyssonen K., Salonen R., Tervahauta A., Korpela H., Lakka T., Kaplan G.A., Salonen J.T. Body iron stores are associated with serum insulin and blood glucose concentrations. Population study in 1013 eastern Finnish men. Diabetes Care. 1997;20:426&#x2013;428. doi: 10.2337/diacare.20.3.426.</Citation><ArticleIdList><ArticleId IdType="doi">10.2337/diacare.20.3.426</ArticleId><ArticleId IdType="pubmed">9051399</ArticleId></ArticleIdList></Reference><Reference><Citation>Yamamoto Y., Otsuka Y., Tokumasu K., Sunada N., Nakano Y., Honda H., Sakurada Y., Hasegawa T., Hagiya H., Otsuka F. Utility of Serum Ferritin for Predicting Myalgic Encephalomyelitis/Chronic Fatigue Syndrome in Patients with Long COVID. J. Clin. Med. 2023;12:4737. doi: 10.3390/jcm12144737.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm12144737</ArticleId><ArticleId IdType="pmc">PMC10381392</ArticleId><ArticleId IdType="pubmed">37510852</ArticleId></ArticleIdList></Reference><Reference><Citation>Postic C., Girard J. Contribution of de novo fatty acid synthesis to hepatic steatosis and insulin resistance: Lessons from genetically engineered mice. J. Clin. Investig. 2008;118:829&#x2013;838. doi: 10.1172/JCI34275.</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI34275</ArticleId><ArticleId IdType="pmc">PMC2254980</ArticleId><ArticleId IdType="pubmed">18317565</ArticleId></ArticleIdList></Reference><Reference><Citation>Sakurai M., Takamura T., Ota T., Ando H., Akahori H., Kaji K., Sasaki M., Nakanuma Y., Miura K., Kaneko S. Liver steatosis, but not fibrosis, is associated with insulin resistance in nonalcoholic fatty liver disease. J. Gastroenterol. 2007;42:312&#x2013;317. doi: 10.1007/s00535-006-1948-.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00535-006-1948-</ArticleId><ArticleId IdType="pubmed">17464461</ArticleId></ArticleIdList></Reference><Reference><Citation>Lv Q., Meng X.F., He F.F., Chen S., Su H., Xiong J., Gao P., Tian X.J., Liu J.S., Zhu Z.H., et al. High serum uric acid and increased risk of type 2 diabetes: A systemic review and meta-analysis of prospective cohort studies. PLoS ONE. 2013;8:e56864. doi: 10.1371/journal.pone.0056864.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0056864</ArticleId><ArticleId IdType="pmc">PMC3577701</ArticleId><ArticleId IdType="pubmed">23437258</ArticleId></ArticleIdList></Reference><Reference><Citation>Tanaka Y., Nagoshi T., Takahashi H., Oi Y., Yoshii A., Kimura H., Ito K., Kashiwagi Y., Tanaka T.D., Yoshimura M. URAT1-selective inhibition ameliorates insulin resistance by attenuating diet-induced hepatic steatosis and brown adipose tissue whitening in mice. Mol. Metab. 2022;55:101411. doi: 10.1016/j.molmet.2021.101411.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.molmet.2021.101411</ArticleId><ArticleId IdType="pmc">PMC8717577</ArticleId><ArticleId IdType="pubmed">34863940</ArticleId></ArticleIdList></Reference><Reference><Citation>Emiroglu C., Dicle M., Yesiloglu C., Gorpelioglu S., Aypak C. Association between newly diagnosed hyperglycemia/diabetes mellitus, atherogenic index of plasma and obesity in post-COVID-19 syndrome patients. Endocrine. 2024;84:470&#x2013;480. doi: 10.1007/s12020-023-03611-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12020-023-03611-4</ArticleId><ArticleId IdType="pubmed">38001321</ArticleId></ArticleIdList></Reference><Reference><Citation>Singh I., Joseph P., Heerdt P.M., Cullinan M., Lutchmansingh D.D., Gulati M., Possick J.D., Systrom D.M., Waxman A.B. Persistent Exertional Intolerance After COVID-19: Insights From Invasive Cardiopulmonary Exercise Testing. Chest. 2022;161:54&#x2013;63. doi: 10.1016/j.chest.2021.08.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.chest.2021.08.010</ArticleId><ArticleId IdType="pmc">PMC8354807</ArticleId><ArticleId IdType="pubmed">34389297</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>